David Dai analyst UBS

Currently out of the existing stock ratings of David Dai, 65 are a BUY (80.25%), 16 are a HOLD (19.75%).

David Dai

Work Performance Price Targets & Ratings Chart

Analyst David Dai, currently employed at UBS, carries an average stock price target met ratio of 43.27% that have a potential upside of 15.85% achieved within 91 days. Previously, David Dai worked at BERNSTEIN.

David Dai’s has documented 165 price targets and ratings displayed on 27 stocks. The coverage is on Healthcare, Technology, Consumer Cyclical, Communication Services sectors.

Most recent stock forecast was given on SNDX, Syndax Pharmaceuticals at 21-Aug-2026.

Wall Street Analyst David Dai

Analyst best performing recommendations are on ARM (ARM HOLDINGS PLC).
The best stock recommendation documented was for ARM (ARM HOLDINGS PLC) at 5/18/2026. The price target of $300 was fulfilled within 4 days with a profit of $84.88 (39.46%) receiving and performance score of 98.64.

Average potential price target upside

INBX Inhibrx JNCE Jounce Therapeutics MGNX MacroGenics NKTX Nkarta ACET Adicet Bio ASML ASML Holding NV ADR BPMC Blueprint Medicines Corp CATX Perspective Therapeutics CGEM Cullinan Oncology LLC CGON CG Oncology IDYA Ideaya Biosciences IOVA Iovance Biotherapeutics KURA Kura Oncology MRUS Merus BV NRIX Nurix Therapeutics NUVL Nuvalent SMMT Summit Therapeutics PLC SNDX Syndax Pharmaceuticals SONY Sony Group Corp ARM Arm Holdings plc BABA Alibaba Group Holding Ltd BIDU Baidu BNTX BioNTech SE JANX Janux Therapeutics JD JD.com Adr TCOM Trip.com Group Ltd ADR ENGN enGene Holdings

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 23-Jul-2024

1 years 2 months 7 days ago
(22-Aug-2025)

6/6 (100%)

$27 (0.00%)

1120

Buy Since 09-Aug-2022

$46

$-62.64 (-57.66%)

$48

3 years 7 months 22 days ago
(07-Mar-2023)

6/6 (100%)

$46 (0.00%)

1384

Buy Since 23-Aug-2022

$45

$-63.64 (-58.58%)

$30

4 years 2 months 6 days ago
(23-Aug-2022)

2/2 (100%)

$45 (0.00%)

1498

Buy

$40

$9.67 (31.88%)

4 years 7 months 12 days ago
(16-Mar-2022)

0/1 (0%)

$17.23 (75.67%)

$60

$1.61 (2.76%)

$30

5 years 16 days ago
(12-Oct-2021)

2/2 (100%)

$60 (0.00%)

1658

Show more analysts

Please expand the browser size to see the chart

Which stock is David Dai most bullish on?

Potential upside of $1051.2 has been obtained for ASML (ASML HOLDING NV ADR)

Which stock is David Dai most reserved on?

Potential downside of -$7.09 has been obtained for IOVA (IOVANCE BIOTHERAPEUTICS)

What Year was the first public recommendation made by David Dai?

On 2017
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?